DAR No 3: Verquvo®. Vericiguat in heart failure

Content tools

Share it

If there is no alternative...

Additional therapy for adults with HF and EF <40% who are stabilised and euvolemic after a recent decompensation event requiring IV diuretics and received best medical care (a betablocker, an ACE-I or ARB or sacubitril/valsartan and a sodium-glucose cotransporter 2 inhibitor).

Download pdf

Enviar comentario

You can send us a comment or suggestion and we will respond to most frequently asked questions

Competing interests (complete this field only if you have competing interests)

First name, middle initial and last name *

Email *

Current position or occupation *

Place of work *

Suggestions/Comments *

navarra.es

DAR No 3: Verquvo®. Vericiguat in heart failure

If there is no alternative...